Multifunctional aspects of allopregnanolone in stress and related disorders

  title={Multifunctional aspects of allopregnanolone in stress and related disorders},
  author={Anjana Bali and Amteshwar Singh Jaggi},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  • Anjana BaliA. Jaggi
  • Published 3 January 2014
  • Biology, Medicine, Psychology
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry

Figures and Tables from this paper

The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD

The neurophysiological role of allopregnanolone both as a potent and positive GABAergic neuromodulator but also in its capacity of inhibiting the HPA axis is reviewed.

Allopregnanolone: An overview on its synthesis and effects

Synthetic analogues or a different therapeutic strategy able to increase allopregnanolone levels have been proposed to overcome any pharmacokinetic issues and a possible gender medicine based on this neuroactive steroid for neurological disorders.

Synthetic Epoxy-Pregnan Steroids: Effects on Anxiety Behavior in Rats

The effect of an intracranial administration of two synthetic steroids, Epoxy 1 and Epoxy 2, in an anxiety animal model is evaluated to provide knowledge about the possible in vivo effects of these steroids.

Allopregnanolone: Regenerative therapeutic to restore neurological health

Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor

Understanding of allopregnanolone’s actions in the VTA for lordosis has been extended to reveal the role ofallopreg nanolone for broader, clinically-relevant questions, such as neurodevelopmental processes, neuropsychiatric disorders, epilepsy, and aging.

Neurosteroids in the Pathophysiology and Treatment of Mood and Anxiety Disorders

There is evidence that many pharmaceuticals used for mood and anxiety disorders including antidepressants, antipsychotics, and mood stabilizers may be effective secondary to their ability to modulate neurosteroids.

Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?

The state of art on this topic is summarized, the key unresolved questions that have emerged on the pharmacological targeting of these enzymes and their products are overview, and the need for further studies to ascertain the severity and duration of the adverse effects of 5α-R inhibitors, as well as their biological underpinnings is highlighted.



Tolerance to allopregnanolone with focus on the GABA‐A receptor

It is shown that both acute and chronic tolerances can develop to the effects of allopregnanolone, and the exact mechanism of the allopreginolone tolerance phenomena remains unclear.

Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation

Protracted social isolation in mice may provide a model to investigate whether 5α-DHP by a genomic action, and ALLO by a nongenomic mechanism down-regulate the action of drugs acting as agonist, partial agonists, or positive allosteric modulators of the benzodiazepine recognition sites expressed by GABAA receptors.

Anxiogenic Effects of Neurosteroid Exposure: Sex Differences and Altered GABAA Receptor Pharmacology in Adult Rats

Although neurosteroid exposure may influence both the pharmacological properties of the GABAA receptor and the manifestation of anxiety in both sexes, the effects of neurosteroids may be modulated in a sex- and task-specific manner.

Decreased Cerebrospinal Fluid Allopregnanolone Levels in Women with Posttraumatic Stress Disorder

Neurosteroids and GABAA Receptor Interactions: A Focus on Stress

How brain-derived neurosteroids may impact on the stress response to acute and chronic challenges, both pre- and postnatally through to adulthood are critically appraised.